共 6 条
[1]
Gene polymorphism of cytochrome P450 2C19*2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis[J] . Xiaowen Hou,Jingpu Shi,Hao Sun.European Journal of Clinical Pharmacology . 2014 (9)
[3]
Personalized antiplatelet therapy according to CYP2C19 genotype after percutaneous coronary intervention: A randomized control trial[J] . Xiang Xie,Yi-Tong Ma,Yi-Ning Yang,Xiao-Mei Li,Ying-Ying Zheng,Xiang Ma,Zhen-Yan Fu,Ba·Bayinsilema,Yan Li,Zi-Xiang Yu,You Chen,Bang-Dang Chen,Fen Liu,Ying Huang,Cheng Liu,Gulinaer Baituola.International Journal of Cardiology . 2013 (4)
[4]
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)[J] . Hani Jneid,Jeffrey L. Anderson,R. Scott Wright,Cynthia D. Adams,Charles R. Bridges,Donald E. Casey,Steven M. Ettinger,Francis M. Fesmire,Theodore G. Ganiats,A. Michael Lincoff,Eric D. Peterson,George J. Philippides,Pierre Theroux,Nanette K. Wenger,James Patrick Zidar.Journal of the America
[6]
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement[J] . Circulation . 2010 (4)